Registry of Chronic Subdural Hematoma
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions: 1. What are the characteristics of patients with CSDH when they are diagnosed? 2. What treatments do patients with CSDH receive? 3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status? Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients diagnosed with CSDH
• 18 years or older
Locations
Other Locations
Netherlands
Amsterdam UMC
RECRUITING
Amsterdam
Erasmus MC
RECRUITING
Rotterdam
Contact Information
Primary
Rahman Fakhry
r.fakhry@erasmusmc.nl
+31 10 7043507
Backup
Dana C. Holl
d.holl@erasmusmc.nl
Time Frame
Start Date: 2021-10-01
Estimated Completion Date: 2028-01
Participants
Target number of participants: 1500
Treatments
CSDH patients
All adult patients diagnosed with chronic subdural hematoma who provide informed consent to participate in the study will be included. Participants will receive standard care, with treatment determined by their treating physician based on clinical judgment. Treatment options may include burr hole drainage, craniotomy, embolization of the middle meningeal artery, pharmacological management, or a wait-and-scan approach. Follow-up will be conducted at 3 months via a telephone interview.
Related Therapeutic Areas
Sponsors
Leads: Erasmus Medical Center